Home>Topics>Companies>Henry Schein

Henry Schein HSIC

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Despite Currency and Vet Supplier Headwinds, Patterson Keeps Performance On Track


      Thu, 21 May 2015

      decision to sell its products directly and cut out the distributors. Patterson's sales were on par with main competitor Henry Schein 's as these companies work through this transition period, and excluding vet diagnostics, this segment posted healthy

    2. Henry Schein Reports in-Line Quarter; Currency Headwinds Evident


      Mon, 4 May 2015

      Henry Schein reported first-quarter results that are in line with our expectations, and we are reiterating our $125 fair values estimate

    3. Amerisource Continues Impressive Results as Firm Delivers a Solid Fiscal 2Q


      Thu, 30 Apr 2015

      it a second tier player within the veterinary distribution market niche. MWI competes with two wide moat players, Henry Schein and Patterson Companies, which makes the production of economic profits challenging for MWI. Nevertheless, we believe

    4. Currency and Dental Equipment Headwinds Suppress Patterson’s Results


      Thu, 19 Feb 2015

      customer appetite for pricier and more discretionary equipment purchases. While Patterson and its primary competitor, Henry Schein , faced weak dental equipment performance at the end of last year on this temporary tax issue, Patterson’s particularly

    5. Strength in Henry Schein's Vet and Medical Segments Helps Offset Temporary Dental Equipment Slump


      Tue, 17 Feb 2015

      Henry Schein 's fourth-quarter results of 7% revenue and 9% adjusted EPS growth continue to mostly track our expectations. We think improving

    6. 2 Wide Moats in Health Care

      Video Reports

      Fri, 14 Nov 2014

      Michael Waterhouse: [TICKER:HSIC] Henry Schein (HSIC) and Patterson (PDCO) are two unique health-care companies that we rate wide moat, and we think they have wide moats

      Henry Schein found at 0:03

      Michael Waterhouse: [TICKER:HSIC] Henry Schein (HSIC) and Patterson (PDCO) are two unique health-care companies that we rate wide moat, and we think they have wide moats for
    7. Dentsply Reports Modest Improvement, but Overall Performance Remains Subdued


      Wed, 29 Oct 2014

      narrow-moat position in the dental supply markets, but we think rising competition in the implant market, such as Henry Schein ’s growing specialty operations, Patterson’s partnership with Straumann, and Danaher’s acquisition of Nobel

    8. Idexx Posts Stellar 3Q, and We Have Raised Our Fair Value Estimate


      Fri, 24 Oct 2014

      products, including the consumables and rapid assay kits that had previously been handled by vet distributors like Henry Schein , is a good strategic move. The reorganization of its salesforce around key account managers offers many opportunities

    9. Nobel’s Second-Quarter Results Reflect Significant Improvement From Turnaround Efforts


      Thu, 21 Aug 2014

      interested parties in gaining access to the high-value implant market. We note that Dentsply and even the distributor Henry Schein have recently utilized acquisitions to enhance their capabilities and market share.

    10. Patterson Posts Decent Quarter as Company Continues Transition


      Thu, 21 Aug 2014

      though management suggested new customer sales for the CEREC platform and other equipment remained strong. In light of Henry Schein ’s recent strong performance in this category, it appears Patterson is yielding some ground it gained over the last

    « Prev12345Next »
    Content Partners